Latest Quarter
2026-03-31
Autonomix Medical Inc Common Stock (AMIX)
Revenue
$0.0
Net Income
-$2.7M
Operating Margin
N/A
Free Cash Flow
-$12.3M
Debt / Assets
22.4%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 3,000 | 0 | 0 | 0 |
| Gross Profit | -3,000 | 0 | 0 | 0 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 1,276,000 | 1,619,000 | 5,167,000 | 1,828,000 |
| Operating Expenses | 2,734,000 | 3,343,000 | 7,534,000 | 3,421,000 |
| Operating Income | -2,737,000 | -3,343,000 | -7,534,000 | -3,421,000 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Income Before Tax | -2,666,000 | -3,261,000 | -7,451,000 | -3,337,000 |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | -2,666,000 | -3,261,000 | -7,451,000 | -3,337,000 |
| Per Share | ||||
| EPS | -0.23 | -0.36 | -1.38 | -1.07 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 12,000 | 0 | 0 | 0 |
| Gross Profit | -12,000 | 0 | 0 | 0 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 9,890,000 | 6,863,000 | 5,249,000 | 1,333,000 |
| Operating Expenses | 17,022,000 | 11,588,000 | 12,030,000 | 1,990,000 |
| Operating Income | -17,034,000 | -11,588,000 | -12,030,000 | -1,990,000 |
| Interest Expense | 0 | 176,000 | 79,000 | 0 |
| Income Before Tax | -16,715,000 | -11,410,000 | -15,426,000 | -1,990,000 |
| Income Tax Expense | 0 | 0 | 0 | -1,990,000 |
| Net Income | -16,715,000 | -11,410,000 | -15,426,000 | -1,990,000 |
| Per Share | ||||
| EPS | -2.32 | -6.46 | -21.10 | -0.11 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Assets | |||
| Cash and Cash Equivalents | 7,004,000 | 9,136,000 | 8,608,000 |
| Short Term Investments | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 |
| Total Current Assets | 7,581,000 | 9,609,000 | 9,391,000 |
| Property Plant Equipment | 19,000 | 21,000 | 16,000 |
| Goodwill and Intangibles | 0 | 0 | 0 |
| Total Assets | 7,600,000 | 9,806,000 | 9,407,000 |
| Liabilities | |||
| Account Payables | 700,000 | 676,000 | 492,000 |
| Short Term Debt | 0 | 0 | 0 |
| Total Current Liabilities | 1,705,000 | 1,707,000 | 777,000 |
| Long Term Debt | 0 | 0 | 1,002,000 |
| Total Liabilities | 1,705,000 | 1,707,000 | 1,779,000 |
| Shareholders Equity | |||
| Retained Earnings | -67,094,000 | -50,379,000 | -38,969,000 |
| Total Shareholders Equity | 5,895,000 | 8,099,000 | 7,628,000 |
| Balance Sheet (Annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Assets | |||
| Cash and Cash Equivalents | 7,004,000 | 9,136,000 | 8,608,000 |
| Short Term Investments | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 |
| Total Current Assets | 7,581,000 | 9,609,000 | 9,391,000 |
| Property Plant Equipment | 19,000 | 21,000 | 16,000 |
| Goodwill and Intangibles | 0 | 0 | 0 |
| Total Assets | 7,600,000 | 9,806,000 | 9,407,000 |
| Liabilities | |||
| Account Payables | 700,000 | 676,000 | 492,000 |
| Short Term Debt | 0 | 0 | 0 |
| Total Current Liabilities | 1,705,000 | 1,707,000 | 777,000 |
| Long Term Debt | 0 | 0 | 1,002,000 |
| Total Liabilities | 1,705,000 | 1,707,000 | 1,779,000 |
| Shareholders Equity | |||
| Retained Earnings | -67,094,000 | -50,379,000 | -38,969,000 |
| Total Shareholders Equity | 5,895,000 | 8,099,000 | 7,628,000 |
| Cash Flow Statement (Quarterly) | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -16,715,000 | -11,410,000 | -15,426,000 |
| Depreciation & Amortization | 12,000 | 183,000 | 81,000 |
| Stock Based Compensation | 529,000 | 1,628,000 | 618 |
| Change in Working Capital | -107,000 | 1,240,000 | 79,000 |
| Operating Cash Flow | -12,282,000 | -8,258,000 | -6,648,000 |
| Investing Activities | |||
| Capital Expenditure | -10,000 | -14,000 | -19,000 |
| Investments | -10,000 | -14,000 | -19,000 |
| Investing Cash Flow | -10,000 | -14,000 | -19,000 |
| Financing Activities | |||
| Debt Repayment | 0 | 0 | 2,000,000 |
| Common Stock Issued/Repurchased | 2,614,000 | 10,027,000 | 13,706,000 |
| Dividends Paid | 0 | 0 | 0 |
| Financing Cash Flow | 10,160,000 | 8,800,000 | 14,410,000 |
| Summary | |||
| Free Cash Flow | -12,292,000 | -8,272,000 | -6,667,000 |
| Net Change in Cash | -2,132,000 | 528,000 | 7,743,000 |
| Cash Flow Statement (Annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -16,715,000 | -11,410,000 | -15,426,000 |
| Depreciation & Amortization | 12,000 | 183,000 | 81,000 |
| Stock Based Compensation | 529,000 | 1,628,000 | 618 |
| Change in Working Capital | -107,000 | 1,240,000 | 79,000 |
| Operating Cash Flow | -12,282,000 | -8,258,000 | -6,648,000 |
| Investing Activities | |||
| Capital Expenditure | -10,000 | -14,000 | -19,000 |
| Investments | -10,000 | -14,000 | -19,000 |
| Investing Cash Flow | -10,000 | -14,000 | -19,000 |
| Financing Activities | |||
| Debt Repayment | 0 | 0 | 2,000,000 |
| Common Stock Issued/Repurchased | 2,614,000 | 10,027,000 | 13,706,000 |
| Dividends Paid | 0 | 0 | 0 |
| Financing Cash Flow | 10,160,000 | 8,800,000 | 14,410,000 |
| Summary | |||
| Free Cash Flow | -12,292,000 | -8,272,000 | -6,667,000 |
| Net Change in Cash | -2,132,000 | 528,000 | 7,743,000 |